Open AccessEffect of Hydrocortisone vs Pasireotide on Pancreatic Surgery Complications in Patients With High Risk of Pancreatic Fistula
Author(s) -
Timo Tarvainen,
Jukka Sirén,
Arto Kokkola,
Ville Sallinen
Publication year - 2020
Publication title -
jama surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.757
H-Index - 176
eISSN - 2168-6262
pISSN - 2168-6254
DOI - 10.1001/jamasurg.2019.6019
Subject(s) - medicine , pasireotide , pancreatic fistula , pancreaticoduodenectomy , hydrocortisone , general surgery , surgery , gastroenterology , pancreas , acromegaly , hormone , growth hormone
Both hydrocortisone and pasireotide have been shown in randomized clinical trials to be effective in reducing postoperative complications of pancreatic surgery, but to date no randomized clinical trial has evaluated the effectiveness of pasireotide compared with hydrocortisone.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom